Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)
Working Capital Ratio
71.73%
Quarterly · Period ending:
CANF Working Capital Ratio
Latest reported71.73%period ending
Latest reported71.73%period ending
CANF Quarterly Working Capital Ratio (13.86% → 71.73%)
Quarterly working capital ratio
High-resolution chart · PNG
CANF working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 71.7318% | |
| 71.7318% | |
| 70.5171% | |
| 70.5171% | |
| 71.2953% | |
| 71.2953% | |
| 75.9868% | |
| 75.9868% | |
| 64.8598% | |
| 64.8598% | |
| 78.9669% | |
| 74.7519% | |
| 78.6439% | |
| 77.7522% | |
| 71.6902% | |
| 76.8849% | |
| 84.3347% | |
| 82.7534% | |
| 85.6071% | |
| 84.1656% | |
| 74.3182% | |
| 82.9226% | |
| 85.3828% | |
| 85.7046% | |
| 87.5234% | |
| 61.6369% | |
| 47.3761% | |
| 58.1057% | |
| 70.9812% | |
| 63.2261% | |
| 60.161% | |
| 67.843% | |
| 63.4468% | |
| 71.9198% | |
| 64.7197% | |
| 83.6225% | |
| 83.9059% | |
| 83.8166% | |
| 74.7603% | |
| 85.7661% | |
| 87.9565% | |
| 86.9638% | |
| 89.518% | |
| 90.0768% | |
| 82.7636% | |
| 74.7009% | |
| 85.043% | |
| 68.9438% | |
| 79.1323% | |
| 81.4872% | |
| 66.9855% | |
| 53.5081% | |
| 64.1835% | |
| 71.0636% | |
| -44.7864% | |
| 48.1826% | |
| 66.5495% | |
| 58.5233% | |
| 70.911% | |
| 13.8551% |